As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...